Table 2.
Measured Aβ1–40 concentration and relative percentages for each plasma sample through multiple freeze/thaw cycles
Cycle 0 |
Cycle 1 |
Cycle 2 |
Cycle 3 |
Cycle 4 |
Cycle 5 |
Averaged relative % | CV, % | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
concentration | relative % | concentration | relative % | concentration | relative % | concentration | relative % | concentration | relative % | concentration | relative % | |||
Sample 1 | 60.21 | 100.00 | 59.20 | 98.32 | 59.86 | 99.42 | 59.44 | 98.72 | 59.58 | 98.95 | 59.00 | 98.00 | 98.68 | 0.7 |
Sample 2 | 58.09 | 100.00 | 58.72 | 101.11 | 58.42 | 100.56 | 57.56 | 99.09 | 56.88 | 97.91 | 55.94 | 96.30 | 98.99 | 1.8 |
Sample 3 | 40.75 | 100.00 | 39.20 | 96.20 | 42.51 | 104.32 | 40.18 | 98.60 | 39.74 | 97.52 | 40.33 | 98.97 | 99.12 | 2.8 |
Sample 4 | 43.26 | 100.00 | 43.03 | 99.47 | 43.52 | 100.60 | 42.65 | 98.59 | 41.15 | 95.12 | 40.58 | 93.80 | 97.52 | 2.9 |
Sample 5 | 45.32 | 100.00 | 46.02 | 101.54 | 46.78 | 103.22 | 45.77 | 100.99 | 46.51 | 102.63 | 46.04 | 101.59 | 101.99 | 1.1 |
Sample 6 | 45.5 | 100.00 | 46.69 | 102.62 | 44.96 | 98.81 | 44.64 | 98.11 | 43.34 | 95.25 | 42.93 | 94.35 | 97.83 | 3.1 |
Sample 7 | 42.97 | 100.00 | 43.21 | 100.56 | 43.85 | 102.05 | 43.14 | 100.40 | 42.89 | 99.81 | 40.30 | 93.79 | 99.32 | 2.9 |
Sample 8 | 41.63 | 100.00 | 40.92 | 98.29 | 41.81 | 100.43 | 41.48 | 99.64 | 41.07 | 98.65 | 41.67 | 100.10 | 99.42 | 0.9 |
Mean ± SD | 100.0+0.000 | 99.79±2.10 | 101.17±1.88 | 99.27±1.00 | 98.23±2.44 | 97.11+3.01 | − | − |
Aβ1–<smallcaps>40</smallcaps> concentrations are presented as pg/mL. SD, standard deviation; CV, coefficient of variation.